Academia at the crossroads: education and training in pharmacogenomics

Personalized Medicine
Lawrence J Lesko, Julie A Johnson

Abstract

Technology and clinical research has catalyzed the growth of pharmacogenomics and personalized medicine. However, adoption of genetic and genomic findings into clinical practice has occurred at a much slower pace. There are a variety of reasons for this but almost everyone has identified education and training of healthcare providers, especially physicians, as an important enabler of personalized medicine. Numerous surveys have found that there is a knowledge gap in that most healthcare providers feel that genomics is an important determinant of disease and drug response but many feel inadequately informed to apply this information. This article explores this issue and proposes a way forward, recognizing that there will not be a one-size-fits-all approach to education and training for physicians and/or other healthcare providers.

References

Apr 30, 2002·Gan to kagaku ryoho. Cancer & chemotherapy·Yutaka TokudaTomoo Tajima
Apr 28, 2004·Journal of General Internal Medicine·Donna M WindishScott M Wright
Apr 26, 2007·Academic Medicine : Journal of the Association of American Medical Colleges·Virginia Carol ThurstonJames Joseph Brokaw
Dec 19, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Myla Lai-Goldman, Hawazin Faruki
Feb 21, 2009·The New England Journal of Medicine·Janet Woodcock, Lawrence J Lesko
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Sep 4, 2010·Academic Medicine : Journal of the Association of American Medical Colleges·M Brownell Anderson, Steven L Kanter
Jan 29, 2011·Clinical Pharmacology and Therapeutics·M V Relling, T E Klein
Jan 27, 2012·Clinical Pharmacology and Therapeutics·E J StanekF W Frueh
Apr 20, 2012·Clinical Pharmacology and Therapeutics·J A JohnsonA R Shuldiner
Mar 1, 2012·Personalized Medicine·Carsten Carlberg
May 1, 2008·Personalized Medicine·MaryRose Barranco Morris, Brian Morris

❮ Previous
Next ❯

Citations

Sep 11, 2013·Therapeutic Advances in Drug Safety·Jivan Moaddeb, Susanne B Haga
Nov 10, 2018·Australian Journal of Primary Health·Vijayaprakash SuppiahElizabeth Hotham
Apr 27, 2019·Personalized Medicine·Richard TaRodolfo Coloso
Nov 20, 2014·Médecine sciences : M/S·Yann Joly, Bartha M Knoppers
Jan 5, 2014·Pharmacogenetics and Genomics·Susanne B Haga, Jivan Moaddeb
Jun 1, 2015·Personalized Medicine·Marie KarlikovaOndrej Topolcan
Mar 1, 2015·Personalized Medicine·Christine M FormeaCarolyn Rohrer Vitek
Jan 1, 2013·Personalized Medicine·Lawrence Lesko

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved